Zymeworks Inc
NASDAQ:ZYME

Watchlist Manager

Zymeworks Inc

NASDAQ:ZYME

Watchlist

Dividends

Price: 12.25 USD -2.39% Market Closed

Market Cap: 843.8m USD

Have any thoughts about
Zymeworks Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 12.25 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

ZYME Alert

Zymeworks Inc

12.25

-0.30 (-2.39%)

52 Week Range	8.11 17.4
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Zymeworks Inc

What unique competitive advantages
does Zymeworks Inc hold over its rivals?

What risks and challenges
does Zymeworks Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Zymeworks Inc.

What unique competitive advantages
does Zymeworks Inc hold over its rivals?

What risks and challenges
does Zymeworks Inc face in the near future?

Has there been any significant insider trading activity
in Zymeworks Inc recently?

Summarize the latest earnings call
of Zymeworks Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Zymeworks Inc.

Provide P/S
for Zymeworks Inc.

Provide P/E
for Zymeworks Inc.

Provide P/OCF
for Zymeworks Inc.

Provide P/FCFE
for Zymeworks Inc.

Provide P/B
for Zymeworks Inc.

Provide EV/S
for Zymeworks Inc.

Provide EV/GP
for Zymeworks Inc.

Provide EV/EBITDA
for Zymeworks Inc.

Provide EV/EBIT
for Zymeworks Inc.

Provide EV/OCF
for Zymeworks Inc.

Provide EV/FCFF
for Zymeworks Inc.

Provide EV/IC
for Zymeworks Inc.

Show me price targets
for Zymeworks Inc made by professional analysts.

What are the Revenue projections
for Zymeworks Inc?

How accurate were the past Revenue estimates
for Zymeworks Inc?

What are the Net Income projections
for Zymeworks Inc?

How accurate were the past Net Income estimates
for Zymeworks Inc?

What are the EPS projections
for Zymeworks Inc?

How accurate were the past EPS estimates
for Zymeworks Inc?

What are the EBIT projections
for Zymeworks Inc?

How accurate were the past EBIT estimates
for Zymeworks Inc?

Compare the revenue forecasts
for Zymeworks Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Zymeworks Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Zymeworks Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Zymeworks Inc compared to its peers.

Compare the P/E ratios
of Zymeworks Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Zymeworks Inc with its peers.

Analyze the financial leverage
of Zymeworks Inc compared to its main competitors.

Show all profitability ratios
for Zymeworks Inc.

Provide ROE
for Zymeworks Inc.

Provide ROA
for Zymeworks Inc.

Provide ROIC
for Zymeworks Inc.

Provide ROCE
for Zymeworks Inc.

Provide Gross Margin
for Zymeworks Inc.

Provide Operating Margin
for Zymeworks Inc.

Provide Net Margin
for Zymeworks Inc.

Provide FCF Margin
for Zymeworks Inc.

Show all solvency ratios
for Zymeworks Inc.

Provide D/E Ratio
for Zymeworks Inc.

Provide D/A Ratio
for Zymeworks Inc.

Provide Interest Coverage Ratio
for Zymeworks Inc.

Provide Altman Z-Score Ratio
for Zymeworks Inc.

Provide Quick Ratio
for Zymeworks Inc.

Provide Current Ratio
for Zymeworks Inc.

Provide Cash Ratio
for Zymeworks Inc.

What is the historical Revenue growth
over the last 5 years for Zymeworks Inc?

What is the historical Net Income growth
over the last 5 years for Zymeworks Inc?

What is the current Free Cash Flow
of Zymeworks Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Zymeworks Inc.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

ZYME Price Targets Summary
Zymeworks Inc

Wall Street analysts forecast ZYME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZYME is 20.85 USD with a low forecast of 12.12 USD and a high forecast of 31.5 USD.

ZYME Average Forecast

Wall Street Target

20.85 USD

70% Upside

ZYME Highest Forecast

Wall Street Target

31.5 USD

157% Upside

Lowest

Price Target

12.12 USD

1% Downside

Average

Price Target

20.85 USD

70% Upside

Highest

Price Target

31.5 USD

157% Upside

Zymeworks Inc Competitors:
Price Targets

LTRN

Lantern Pharma Inc.

491% Upside

OXB

Oxford BioMedica PLC

90% Upside

300122

Chongqing Zhifei Biological Products Co Ltd

34% Upside

BSLN

Basilea Pharmaceutica AG

78% Upside

LTRN

Lantern Pharma Inc.

491% Upside

OXB

Oxford BioMedica PLC

90% Upside

300122

Chongqing Zhifei Biological Products Co Ltd

34% Upside

BSLN

Basilea Pharmaceutica AG

78% Upside

298380

ABL Bio Inc

39% Upside

603087

Gan & Lee Pharmaceuticals

34% Upside

6955

Shandong Boan Biotechnology Co Ltd

14% Upside

9926

Akeso Inc

9% Upside

Revenue
Forecast

Revenue Estimate
Zymeworks Inc

For the last 8 years the compound annual growth rate for Zymeworks Inc's revenue is 29%. The projected CAGR for the next 4 years is 19%.

29%

Past Growth

19%

Estimated Growth

Estimates Accuracy

Average Beat

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Zymeworks Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-11%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Zymeworks Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-34%

Average Miss

What are analyst estimates?

What is ZYME's stock price target?

Price Target
20.85 USD

According to Wall Street analysts, the average 1-year price target for ZYME is 20.85 USD with a low forecast of 12.12 USD and a high forecast of 31.5 USD.

What is Zymeworks Inc's Revenue forecast?

Projected CAGR
19%

For the last 8 years the compound annual growth rate for Zymeworks Inc's revenue is 29%. The projected CAGR for the next 4 years is 19%.

	Roblox Corp NYSE:RBLX	56.51 USD 1.4%
	New York Mortgage Trust Inc NASDAQ:NYMT	6.83 USD 3.8%
	Kolibri Global Energy Inc TSX:KEI	10.93 CAD 2.63%
	Zymeworks Inc NASDAQ:ZYME	12.25 USD -2.39%
	JBS SA BOVESPA:JBSS3	33.23 BRL 0.79%
	Sao Martinho SA BOVESPA:SMTO3	22.2 BRL 3.06%

	Franklin Covey Co NYSE:FC	30.6 USD 2.55%
	Mohawk Industries Inc NYSE:MHK	114.3 USD 3.05%
	Ardmore Shipping Corp NYSE:ASC	9.89 USD 0.41%
	ASGN Inc NYSE:ASGN	68.05 USD 1.52%
	Skyworks Solutions Inc NASDAQ:SWKS	69.4 USD 3.29%
	Weatherford International PLC NASDAQ:WFRD	53.11 USD 2.35%

	Johnson & Johnson NYSE:JNJ	162.81 USD -0.11%
	Bank of America Corp NYSE:BAC	40.89 USD 3.08%
	Mastercard Inc NYSE:MA	527.64 USD 1.5%
	Salesforce Inc NYSE:CRM	279.4 USD 2.82%
	Abbvie Inc NYSE:ABBV	211.77 USD 0.1%
	Home Depot Inc NYSE:HD	351.31 USD 1.17%

	Arista Networks Inc NYSE:ANET	83.51 USD 4.21%
	Visa Inc NYSE:V	331.8 USD 0.99%
	Texas Pacific Land Corp NYSE:TPL	1 321.07 USD 5.28%
	KLA Corp NASDAQ:KLAC	713 USD 4.62%
	Manhattan Associates Inc NASDAQ:MANH	172.5 USD 5.5%
	Monolithic Power Systems Inc NASDAQ:MPWR	606.06 USD 6.1%

	ServiceNow Inc NYSE:NOW	844.33 USD 4.03%
	EOG Resources Inc NYSE:EOG	123.92 USD 2.34%
	Monster Beverage Corp NASDAQ:MNST	55.09 USD 1.38%
	Copart Inc NASDAQ:CPRT	52.65 USD 0.67%
	Applied Materials Inc NASDAQ:AMAT	155.66 USD 3.81%
	Airbnb Inc NASDAQ:ABNB	122.86 USD 2.92%

Zymeworks Inc
NASDAQ:ZYME